Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite

Cell Host & Microbe(2021)10.1016/j.chom.2021.03.005Source: DataRank Database

Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite is a research paper published in Cell Host & Microbe (2021). On theSindex it has a DataRank of 0. It has been cited 587 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access587 citations

Download PDF

Cite:

Linked data & code

bioproject gen emdb uniprot pdb doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (23 grants)Impact (FWCI 32.64)OA: bronzeTopics (43)IDs (PubMed, PMC, OpenAlex)Annotations (6)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (23)

Yicheng Guo ORCID,Tongqing Zhou ORCID,Jason Gorman ORCID,Myungjin Lee ORCID,Micah Rapp ORCID

Live enrichment

PubMed:33789084 PMC:PMC7953435 OpenAlex:https://openalex.org/W3136437538

Simons Foundation

Grant: SF349247

National Institute of General Medical Sciences

Grant: GM103310

National Institute of General Medical Sciences

Grant: GM129539

National Institutes of Health

Grant: P41 GM103403

National Institutes of Health

Grant: P30 GM124165

Office of Science

Grant: W-31-109-Eng-38

NIH HHS

Grant: DP5 OD023118

NIGMS NIH HHS

Grant: U24 GM129539

NIAID NIH HHS

Grant: R21 AI144408

NIAID NIH HHS

Grant: R21 AI143407

NIGMS NIH HHS

Grant: P41 GM103310

Intramural NIH HHS

Grant: ZIA AI005022

National Institutes of Health

Grant: 3P30GM124165-03S1

NE-CAT: A Resource for Advanced Macromolecular Crystallography

National Institutes of Health

Grant: 7P41GM103310-14

National Resource for Automated Molecular Microscopy

National Institutes of Health

Grant: 3DP5OD023118-05S1

Antibody display libraries for precision screening of antibody immune responses to SARS-CoV-2

National Institutes of Health

Grant: 1R21AI144408-01

Probing antigen specificity and response of autoimmune B cells in Neuromyelitis Optica

National Institutes of Health

Grant: 1R21AI143407-01

Comprehensive molecular and functional analyses of anti-HIV-1 broadly neutralizing antibody repertoires

National Institutes of Health

Grant: 5U24GM129539-04

NCCAT: National Center for CryoEM Access and Training

Empire State Development's Division of Science, Technology and Innovation

Vaccine Research Center

Basic Energy Sciences

National Institute of Allergy and Infectious Diseases

U.S. Department of Energy

FWCI

32.64

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

bronzeLicense: Elsevier Non-Commercial

journalhttp://www.cell.com/article/S1931312821001335/pdf

publisherhttp://www.cell.com/article/S1931312821001335/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1931312821001335?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1931312821001335?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.chom.2021.03.005

Fields of Study

SARS-CoV-2 and COVID-19 ResearchBacteriophages and microbial interactionsViral gastroenteritis research and epidemiology0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Protein DomainsSARS-CoV-2Antibodies, ViralHumansMutationProtein ConformationAntibodies, NeutralizingSpike Glycoprotein, Coronavirus

Keywords

AntibodyEpitopeBiologyGlycanVirologyNeutralizing antibodySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)NeutralizationSingle-domain antibodySpike ProteinCoronavirus disease 2019 (COVID-19)Molecular biologyGlycoproteinImmunologyMedicineN-terminal domainAntibody ClassCovid-19Sars-cov-2Multi-Donor AntibodyAntigenic SupersiteProtein DomainsProtein ConformationMutationSpike Glycoprotein, CoronavirusHumansAntibodies, ViralAntibodies, NeutralizingArticle

Sustainable Development Goals

SDG 3: 3. Good health